Oxidation of 1-chloropyrene by human CYP1 family and CYP2A subfamily cytochrome P450 enzymes: catalytic roles of two CYP1B1 and five CYP2A13 allelic variants

References

• Aklillu E, Øvrebø S, Botnen IV, et al. (2005). Characterization of common CYP1B1 variants with different capacity for benzo[a]pyrene-7,8-dihydrodiol epoxide formation from benzo[a]pyrene. Cancer Res 65:5105–11
   PubMed Web of Science ®Google Scholar
• Bhatia AL, Tausch H, Stehlik G. (1987). Mutagenicity of chlorinated polycyclic aromatic compounds. Ecotoxicol Environ Saf 14:48–55
   PubMed Web of Science ®Google Scholar
• Brown RE, Jarvis KL, Hyland KJ. (1989). Protein measurement using bicinchoninic acid: elimination of interfering substances. Anal Biochem 180:136–9
   PubMed Web of Science ®Google Scholar
• Colmsjö A, Rannug A, Rannug U. (1984). Some chloro derivatives of polynuclear aromatic hydrocarbons are potent mutagens in Salmonella typhimurium. Mutat Res 135:21–9
   PubMed Web of Science ®Google Scholar
• Cui L, Dillehay K, Chen W, et al. (2012). Association of the CYP1B1 Leu432Val polymorphism with the risk of prostate cancer: a meta-analysis. Mol Biol Rep 39:7465–71
   PubMed Web of Science ®Google Scholar
• D'Agostino J, Zhang X, Wu H, et al. (2008). Characterization of CYP2A13*2, a variant cytochrome P450 allele previously found to be associated with decreased incidences of lung adenocarcinoma in smokers. Drug Metab Dispos 36:2316–23
   PubMed Web of Science ®Google Scholar
• DeVore NM, Smith BD, Wang JL, et al. (2009). Key residues controlling binding of diverse ligands to human cytochrome P450 2A enzymes. Drug Metab Dispos 37:1319–27
   PubMed Web of Science ®Google Scholar
• DeVore NM, Scott EE. (2012a). Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone binding and access channel in human cytochrome P450 2A6 and 2A13 enzymes. J Biol Chem 287:26576–85
   PubMed Web of Science ®Google Scholar
• DeVore NM, Meneely KM, Bart AG, et al. (2012b). Structural comparison of cytochromes P450 2A6, 2A13, and 2E1 with pilocarpine. FEBS J 279:1621–31
   PubMed Web of Science ®Google Scholar
• Guengerich FP. (2015) Human cytochrome P450 enzymes, in Cytochrome P450: Structure, Mechanism, and Biochemistry. In: Ortiz de Montellano PR, ed. 4th ed. New York: Springer, 523–785
   Google Scholar
• Han S, Choi S, Chun YJ, et al. (2012). Functional characterization of allelic variants of polymorphic human cytochrome P450 2A6 (CYP2A6*5, *7, *8, *18, *19, and *35). Biol Pharm Bull 35:394–9
   PubMed Web of Science ®Google Scholar
• Hecht SS. (2008). Progress and challenges in selected areas of tobacco carcinogenesis. Chem Res Toxicol 21:160–71
   PubMed Web of Science ®Google Scholar
• Kakimoto K, Nagayoshi H, Konishi Y, et al. (2014). Atmospheric chlorinated polycyclic aromatic hydrocarbons in East Asia. Chemosphere 111:40–6
   PubMed Web of Science ®Google Scholar
• Kakimoto K, Nagayoshi H, Inazumi N, et al. (2015). Identification and characterization of oxidative metabolites of 1-chloropyrene. Chem Res Toxicol 28:1728–36
   PubMed Web of Science ®Google Scholar
• Kakimoto K, Nagayoshi H, Konishi Y, et al. (2017). Size distribution of chlorinated polycyclic aromatic hydrocarbons in atmospheric particles. Arch Environ Contam Toxicol 72:58–64
   PubMed Web of Science ®Google Scholar
• Liu Y, Lin CS, Zhang AM, et al. (2014). The CYP1B1 Leu432Val polymorphism and risk of urinary system cancers. Tumour Biol 35:4719–25
   PubMed Web of Science ®Google Scholar
• Ma J, Chen Z, Wu M, et al. (2013). Airborne PM2.5/PM10-associated chlorinated polycyclic aromatic hydrocarbons and their parent compounds in a suburban area in Shanghai, China. Environ Sci Technol 47:7615–23
   PubMed Web of Science ®Google Scholar
• Ohura T, Miwa M. (2016). Photochlorination of polycyclic aromatic hydrocarbons in acidic brine solution. Bull Environ Contam Toxicol 96:524–9
   PubMed Web of Science ®Google Scholar
• Ohura T, Kitazawa A, Amagai T. (2004). Seasonal variability of 1-chloropyrene on atmospheric particles and photostability in toluene. Chemosphere 57:831–7
   PubMed Web of Science ®Google Scholar
• Ohura T, Kitazawa A, Amagai T, Makino M. (2005). Occurrence, profiles, and photostabilities of chlorinated polycyclic aromatic hydrocarbons associated with particulates in urban air. Environ Sci Technol 39:85–91
   PubMed Web of Science ®Google Scholar
• Ohura T, Fujima S, Amagai T, Shinomiya M. (2008). Chlorinated polycyclic aromatic hydrocarbons in the atmosphere: seasonal levels, gas-particle partitioning, and origin. Environ Sci Technol 42:3296–302
   PubMed Web of Science ®Google Scholar
• Ohura T, Morita M, Makino M, et al. (2007). Aryl hydrocarbon receptor-mediated effects of chlorinated polycyclic aromatic hydrocarbons. Chem Res Toxicol 20:1237–41
   PubMed Web of Science ®Google Scholar
• Omura T, Sato R. (1964). The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239:2370–8
   PubMed Web of Science ®Google Scholar
• Parikh A, Gillam EMJ, Guengerich FP. (1997). Drug metabolism by Escherichia coli expressing human cytochromes P450. Nat Biotechnol 15:784–8
   PubMed Web of Science ®Google Scholar
• Sandhu P, Baba T, Guengerich FP. (1993). Expression of modified cytochrome P450 2C10 (2C9) in Escherichia coli, purification, and reconstitution of catalytic activity. Arch Biochem Biophys 306:443–50
   PubMed Web of Science ®Google Scholar
• Sandhu P, Guo Z, Baba T, et al. (1994). Expression of modified human cytochrome P450 1A2 in Escherichia coli: Stabilization, purification, spectral characterization, and catalytic activities of the enzyme. Arch Biochem Biophys 309:168–77
   PubMed Web of Science ®Google Scholar
• Shiraishi H, Pilkington NH, Otsuki A, Fuwa K. (1985). Occurrence of chlorinated polynuclear aromatic hydrocarbons in tap water. Environ Sci Technol 19:585–90
   PubMed Web of Science ®Google Scholar
• Shimada T. (2006). Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metab Pharmacokinet 21:257–76
   PubMed Web of Science ®Google Scholar
• Shimada T. (2017). Inhibition of carcinogen-activating cytochrome P450 enzymes by xenobiotic chemicals in relation to antimutagenicity and anticarcinogenicity. Toxicol Res 33:79–96
   PubMed Web of Science ®Google Scholar
• Shimada T, Watanabe J, Kawajiri K, et al. (1999). Catalytic properties of polymorphic human cytochrome P450 1B1 variants. Carcinogenesis 20:1607–13
   PubMed Web of Science ®Google Scholar
• Shimada T, Tsumura F, Gillam EM, et al. (2000). Roles of NADPH-P450 reductase in the O-deethylation of 7-ethoxycoumarin by recombinant human cytochrome P450 1B1 variants in Escherichia coli. Protein Expr Purif 20:73–80
   PubMed Web of Science ®Google Scholar
• Shimada T, Watanabe J, Guengerich FP, et al. (2001a). Specificity of 17β-estradiol and benzo[a]pyrene oxidations by polymorphic human cytochrome P450 1B1 variants substituted at residues 48, 119 and 432. Xenobiotica 31:163–76
   PubMed Web of Science ®Google Scholar
• Shimada T, Oda Y, Gillam EMJ, et al. (2001b). Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and othwe human cytochromes P450 in Salmonella typhimurium NM2009. Drug Metab Dispos 29:1176–82
   PubMed Web of Science ®Google Scholar
• Shimada T, Tanaka K, Takenaka S, et al. (2009). Reverse type I binding spectra of human cytochrome P450 1B1 induced by derivatives of flavonoids, stilbenes, pyrenes, naphthalenes, phenanthrenes, and biphenyls that Inhibit catalytic activity: Structure-function relationships. Chem Res Toxicol 22:1325–33
   PubMed Web of Science ®Google Scholar
• Shimada T, Tanaka K, Takenaka S, et al. (2010). Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives. Chem Res Toxicol 23:1921–35
   PubMed Web of Science ®Google Scholar
• Shimada T, Murayama N, Tanaka K, et al. (2011). Spectral modification and catalytic inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2A6, and 2A13 by four chemopreventive organoselenium compounds. Chem Res Toxicol 24:1327–37
   PubMed Web of Science ®Google Scholar
• Shimada T, Kim D, Murayama N, et al. (2013). Binding of diverse environmental chemicals with human cytochromes P450 2A13, 2A6, and 1B1 and enzyme inhibition. Chem Res Toxicol 26:517–28
   PubMed Web of Science ®Google Scholar
• Shimada T, Takenaka S, Murayama N, et al. (2015). Oxidation of acenaphthene and acenaphthylene by human cytochrome P450 enzymes. Chem Res Toxicol 28:268–78
   PubMed Web of Science ®Google Scholar
• Shimada T, Takenaka S, Murayama N, et al. (2016a). Oxidation of pyrene, 1-hydroxypyrene, 1-nitropyrene and 1-acetylpyrene by human cytochrome P450 2A13. Xenobiotica 46:211–24
   PubMed Web of Science ®Google Scholar
• Shimada T, Takenaka S, Kakimoto K, et al. (2016b). Structure-function studies of naphthalene, phenanthrene, biphenyl, and their derivatives in interaction with and oxidation by cytochromes P450 2A13 and 2A6. Chem Res Toxicol 29:1029–40
   PubMed Web of Science ®Google Scholar
• Shimada T, Kakimoto K, Takenaka S, et al. (2016c). Roles of human CYP2A6 and monkey CYP2A24 and 2A26 cytochrome P450 enzymes in the oxidation of 2,5,2′,5′-tetrachlorobiphenyl. Drug Metab Disp 44:1899–909
   PubMed Web of Science ®Google Scholar
• Smith BD, Sanders JL, Porubsky PR, et al. (2007). Structure of the human lung cytochrome P450 2A13. J Biol Chem 282:17306–13
   PubMed Web of Science ®Google Scholar
• Sugiyama H, Katagiri Y, Kaneko M, et al. (1999). Chlorination of pyrene in soil components with sodium chloride under xenon irradiation. Chemosphere 38:1937–45
   Web of Science ®Google Scholar
• Tamaki Y, Honda M, Muroi Y, et al. (2011). Novel single nucleotide polymorphism of the CYP2A13 gene in Japanese individuals. Drug Metab Pharmacokinet 226:544–7
   Web of Science ®Google Scholar
• Wang H, Tan W, Hao B, et al. (2003). Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK. Cancer Res 63:8057–61
   PubMed Web of Science ®Google Scholar
• Wang A, Savas U, Stout CD, Johnson EF. (2011). Structural characterization of the complex between alpha-naphthoflavone and human cytochrome P450 1B1. J Biol Chem 286:5736–43
   PubMed Web of Science ®Google Scholar
• Walsh AA, Szklarz GD, Scott EE. (2013). Human cytochrome P450 1A1 structure and utility in understanding drug and xenobiotic metabolism. J Biol Chem 288:12932–43
   PubMed Web of Science ®Google Scholar
• Watanabe J, Shimada T, Gillam EMJ, et al. (2000). Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer. Pharmacogenetics 10:25–33
   PubMedGoogle Scholar
• Xie Y, Liu GQ, Miao XY, et al. (2012). CYP1B1 Leu432Val polymorphism and colorectal cancer risk among Caucasians: a meta-analysis. Tumour Biol 33:809–16
   PubMed Web of Science ®Google Scholar
• Yamazaki H, Nakamura M, Komatsu T, et al. (2002). Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli. Protein Expr Purif 24:329–37
   PubMed Web of Science ®Google Scholar
• Yang J, Xu DL, Lu Q, et al. (2012). Prostate cancer risk and aggressiveness associated with the CYP1B1 4326C/G (Leu432Val) polymorphism: a meta-analysis of 2788 cases and 2968 controls. Asian J Androl 14:560–5
   PubMed Web of Science ®Google Scholar
• Yano JK, Hsu MH, Griffin KJ, et al. (2005). Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen. Nat Struct Mol Biol 12:822–3
   PubMed Web of Science ®Google Scholar
• Zhang X, Su T, Zhang QY, et al. (2002). Genetic polymorphisms of the human CYP2A13 gene: Identification of single-nucleotide polymorphisms and functional characterization of an Arg257Cys variant. J Pharmacol Exp Ther 302:416–23
   PubMed Web of Science ®Google Scholar